List of Excipients in API venlafaxine hydrochloride, extended release
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing venlafaxine hydrochloride, extended release
Detailed excipient profiles for venlafaxine hydrochloride, extended release
Excipient focus: CARNAUBA WAX
venlafaxine hydrochloride, extended release drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
venlafaxine hydrochloride, extended release drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
venlafaxine hydrochloride, extended release drug variants containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
venlafaxine hydrochloride, extended release drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
venlafaxine hydrochloride, extended release drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
venlafaxine hydrochloride, extended release drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ACETATE
venlafaxine hydrochloride, extended release drug variants containing POLYVINYL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing POLYVINYL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
venlafaxine hydrochloride, extended release drug variants containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
venlafaxine hydrochloride, extended release drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
venlafaxine hydrochloride, extended release drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
venlafaxine hydrochloride, extended release drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
venlafaxine hydrochloride, extended release drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARETH-20
venlafaxine hydrochloride, extended release drug variants containing STEARETH-20
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing STEARETH-20
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
venlafaxine hydrochloride, extended release drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
venlafaxine hydrochloride, extended release drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
venlafaxine hydrochloride, extended release drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
venlafaxine hydrochloride, extended release drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | venlafaxine hydrochloride, extended release | 42799-962 |
| >Company | >Ingredient | >NDC |
venlafaxine hydrochloride, extended release drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links